跳至主要内容
临床试验/EUCTR2010-018604-85-SE
EUCTR2010-018604-85-SE进行中(未招募)不适用

Randomized study of yohimbine treatment for type 2 diabetes patients carrying a specific genetic risk variant

und University0 个研究点开始时间: 2011年6月29日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Written informed consent
  • Males between 18 and 70 years; postmenopausal women below 70 years
  • C-peptide 0.35-1.8 nmol/L
  • HbA1c = 80 mmol/mol according to IFCC
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 280
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 280

排除标准

  • Ongoing treatment with insulin, other injected antidiabetic treatment, or oral antidiabetic treatment except metformin
  • GAD antibodies
  • Dysregulated hypertension
  • Known coronary artery disease or arrythmia
  • Known current or previous ventricular or duodenal ulcer
  • Known anxiety syndrome
  • Ongoing treatment with alpha- or beta-adrenergic blockers
  • Creatinine > 130 micromol/L
  • Liver failure
  • Mental disability

研究者

发起方
und University

相似试验